A Clinical Study to Evaluate the Safety, Tolerability, and Efficacy of Intracerebral Injection of LY-N001 Injection for the Treatment of Moderate to Advanced Parkinson's Disease With GBA1 Mutations

Produodopa’s positive RWE for Parkinson’s disease to boost clinician confidence in crowded levodopa market, says GlobalData

Allen Institute launches $400M Brain Health accelerator to develop genetic therapies for neurodegenerative diseases

The Allen Institute in Seattle has launched the Brain Health accelerator, a $400 million initiative aimed at developing genetic therapies (i

https://doi.org/10.1001/jamaneurol.2026.1021

https://doi.org/10.1001/jamaneurol.2026.0989

AI accelerates search for motor neurone disease treatments by repurposing existing drugs

Researchers are using AI to accelerate the search for drugs to treat motor neurone disease (MND). By repurposing existing approved drugs, th

Neurogene Completes Dosing in Registrational Trial of NGN-401 Gene Therapy for Rett Syndrome; Topline Data Expected 2H 2027

Neurogene Inc. has completed dosing in its Embolden registrational trial of NGN-401, a gene therapy for Rett syndrome, exceeding the target